EFFECT OF LONG-ACTING ANTAGONISTS OF GROWTH-HORMONE (GH)-RELEASING HORMONE ON GH AND CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE RELEASE IN SUPERFUSED RAT PITUITARY-CELLS
Je. Horvath et al., EFFECT OF LONG-ACTING ANTAGONISTS OF GROWTH-HORMONE (GH)-RELEASING HORMONE ON GH AND CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE RELEASE IN SUPERFUSED RAT PITUITARY-CELLS, Endocrinology, 136(9), 1995, pp. 3849-3855
In a recent study, investigating the time course of both GH and cAMP s
ecretion induced by GH-releasing hormone (GHRH) in the superfusion sys
tem, we found that the amount of cAMP liberated from the cells was not
proportional to GH release and that cAMP discharged after a GHRH puls
e alone cannot maintain the release of GH. In the present study, two p
otent antagonists of GHRH, MZ-4-71 Ibu(0),D-Arg(2),Phe(4-Cl)(6),Abu(15
),Nle(27)]human GHRH-(1-28)Agm) and MZ-4-243 ([Nac(0),D-Arg(2),Phe(4-C
l)(6),Abu(15) Nle(27)]human GHRH-(1-28)Agm) were evaluated for their l
ong term effect in the superfusion system and for their ability to inf
luence the release of GH and cAMP. Our present findings showed that af
ter a 9-min preincubation, antagonist MZ-4-71 and MZ-4-243 at 3 and 1
nM, respectively, caused an inhibition of GH release, stimulated by 1
nM GHRH, similar to that caused by the 100-nM dose of the standard ant
agonist ([Ac-Tyr(1),D-Arg(2)]human GHRH-(1-29)NH2). The standard antag
onist at 100 nM did not influence the GHRH-induced GH response 30 min
later, and the inhibition caused by MZ-4-71 at 30 nM decreased gradual
ly to 30% 120 min after the treatment, but the 30-nM dose of MZ-4-243
reduced the GH response by more than 90% even 270 min after its admini
stration. During a 2-h incubation with 1 nM GHRH in combination with a
30-min infusion of the standard antagonist, MZ-4-71, MZ-4 -243, or so
matostatin, from the 30th to the 60th min, the decrease in GH discharg
e preceded the inhibition of cAMP release. After infusion of the antag
onists or somatostatin was stopped, GH release resumed sooner than tha
t of cAMP. Simultaneous determinations of cAMP and GH in the samples s
howed that changes in GH levels were never preceded by a rise or decre
ase in cAMP release, in contrast to existing information. The particip
ation of more than one signal transduction mechanism in the mediation
of the effect of GHRH is very likely, and the balance of these mechani
sms may vary with the dose and duration of stimulation.